EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life‐Course Adiposity Polygenic Risk

Linjing Zhang iD, Leyuan Zhang iD, Yongping Zheng iD, Zhenhuang Zhuang, Lu Tang iD, Wei Zheng, Kailin Xia, Shan Ye, Tielun Yin, Tao Huang iD, Dongsheng Fan iD

Journal of Cachexia, Sarcopenia and Muscle · 2026

DOI: 10.1002/jcsm.70410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Linjing Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Adiposity, Lipidomics, Lipids. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Cohort Construction Program of Peking University Third Hospital, National Clinical Key Specialty Construction Program of China (2024).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Although both pre‐symptomatic adiposity and dysregulated lipid metabolism are implicated in amyotrophic lateral sclerosis (ALS), the mechanistic pathways linking adiposity to disease remain unclear. This study aimed to investigate how genetic predisposition to adiposity might influence ALS through specific lipid metabolic pathways.

Methods

We conducted mass spectrometry–based quantitative lipidomics on plasma from 104 ALS patients and 78 age‐ and sex‐matched controls. Life‐course adiposity polygenic risk scores (PRS) for birth weight, body fat percentage, appendicular lean mass and whole‐body fat‐free mass were constructed. Associations and PRS‐by‐disease interaction effects on the lipidome were evaluated.

Results

Compared to controls, ALS patients exhibited widespread lipid dysregulation. Seventy‐eight lipid species were significantly altered (FDR < 0.05, |Cohen's d | > 1.0), characterized by a predominant decrease in acylcarnitines (75% of species) and distinct shifts within sphingolipid and glycerophospholipid subclasses. A three‐acylcarnitine candidate panel (C10:0, C12:0 and C18:2) using fivefold analysis with feature selection repeated within each training fold yielded an overall out‐of‐fold AUC of 0.958. Exploratory PRS‐by‐disease‐status analyses identified 16 nominal interaction signals, including 13 acylcarnitines; no significant mediation effect of lipids between PRS and ALS risk was detected.

Conclusion

These findings identify robust ALS‐associated plasma lipid alterations, and our exploratory findings suggest that genetic predisposition to adiposity may shape the pattern of lipid metabolic disruption in ALS, offering new insights into the disease's metabolic pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAdiposityLipidomicsLipidsMultifactorial InheritanceHumansFemaleGenetic Risk ScoreMaleMiddle AgedGenetic Predisposition to DiseaseLipid MetabolismAgedRisk FactorsBiomarkers

Stichwörter der Autor:innen

adiposityamyotrophic lateral sclerosisgene–environment interactionlipidomicpolygenic risk score

Substanzen

LipidsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Peking University Third Hospital, Beijing, China.
  • Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Department of Radiation Oncology, Peking University Third Hospital, Beijing, China.
  • Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, China.

ORCID-Profile: Linjing Zhang, Leyuan Zhang, Yongping Zheng, Lu Tang, Tao Huang, Dongsheng Fan

Förderung

  • National Natural Science Foundation of China
  • Clinical Cohort Construction Program of Peking University Third Hospital
  • National Clinical Key Specialty Construction Program of China (2024)
  • Peking University Clinical Scientist Training Program
  • Young Elite Scientists Sponsorship Program of the Beijing High Innovation Plan

Zitieren

APA

Zhang, L., Zhang, L., Zheng, Y., Zhuang, Z., Tang, L., Zheng, W., Xia, K., Ye, S., Yin, T., Huang, T., & Fan, D. (2026). Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life‐Course Adiposity Polygenic Risk. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70410

Vancouver

Zhang L, Zhang L, Zheng Y, Zhuang Z, Tang L, Zheng W, et al. Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life‐Course Adiposity Polygenic Risk. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70410

BibTeX
@article{Zhang2026,
  author = {Zhang, Linjing and Zhang, Leyuan and Zheng, Yongping and Zhuang, Zhenhuang and Tang, Lu and Zheng, Wei and Xia, Kailin and Ye, Shan and Yin, Tielun and Huang, Tao and Fan, Dongsheng},
  title = {Plasma Lipidome Is Dysregulated in Amyotrophic Lateral Sclerosis and Associated With Life‐Course Adiposity Polygenic Risk},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  doi = {10.1002/jcsm.70410}
}
Kostenlos starten →